UK markets closed
NIKKEI 225
38,471.20 -761.60 (-1.94%) HANG SENG
16,248.97 -351.49 (-2.12%) CRUDE OIL
85.43 +0.02 (+0.02%) GOLD FUTURES
2,409.80 +26.80 (+1.12%) DOW
37,927.47 +192.36 (+0.51%) Bitcoin GBP
50,676.56 -104.78 (-0.21%)
Haleon plc (HLN.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 04:35PM BST
| Previous close | 323.70 |
| Open | 320.80 |
| Bid | 310.00 x N/A |
| Ask | 330.00 x N/A |
| Day's range | 320.00 - 323.10 |
| 52-week range | 306.80 - 357.65 |
| Volume | |
| Avg. volume | 28,560,217 |
| Market cap | 29.415B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 29.28 |
| EPS (TTM) | 0.11 |
| Earnings date | 29 Feb 2024 |
| Forward dividend & yield | 0.06 (1.85%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | 363.07 |
Simply Wall St.Haleon plc (LON:HLN) Shares Could Be 24% Above Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Haleon fair value estimate is UK£2.62 Haleon is estimated to...
ZacksPharma Stock Roundup: AZN to Buy FUSN, PFE to Sell Stake in HLN & Other Updates
AstraZeneca (AZN) is set to acquire Fusion Therapeutics (FUSN). Pfizer (PFE) plans to sell some shares of Haleon to lower stake from 32% to 24%.
ZacksGSK Outperforms Industry on Strength in Key Drugs & Vaccines
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates should drive the stock in the future quarters.
© 2024 Yahoo. All rights reserved.